Why the study?
The WHO Global Action Plan requests stringent control of potentially poliovirus-infected materials amid concerns over vaccine-derived poliovirus.
Answers are grounded in this paper and cite their sources.
The generation of a poliovirus-nonsusceptible Vero cell line provides a safe platform for isolating emerging viruses without the risk of generating potentially PV-infected materials, supporting the WHO Global Action Plan.
Polio or poliomyelitis is a disabling and life-threatening disease caused by poliovirus (PV). As a consequence of global polio vaccination efforts, wild PV serotypes 2 and 3 have been eradicated around the world, and wild PV serotype 1-transmitted cases have been largely eliminated except for limited regions. However, vaccine-derived PV, pathogenically reverted live PV vaccine strains, has become a serious issue. For the global eradication of polio, the World Health Organization is conducting the third edition of the Global Action Plan, which is requesting stringent control of potentially PV-infected materials. To facilitate the mission, we generated a PV-nonsusceptible Vero cell subline, which may serve as an ideal replacement of standard Vero cells to isolate emerging/re-emerging viruses without the risk of generating PV-infected materials.
No takes yet. Share an insight, caveat, or question.
Okemoto‐Nakamura et al. (2021) studied Poliovirus infection (in vitro). CRISPR/Cas9 knockout of PVR1 and PVR2 vs. Parental Vero cells was evaluated on Poliovirus susceptibility and replication.
Synapse has enriched 10 related papers. Consider them for comparative context: